US Patent Number
The present invention relates to pharmaceutical compositions for intranasal administration to a mammal that contain an effective amount of an opioid, a liquid nasal carrier for the opioid, and optionally a sweetener, flavoring agent or masking agent. In some embodiments of the present invention, the pharmaceutical compositions have improved bioavailability. In other embodiments of the present invention, the opioid compositions improve patient compliance.
University of Kentucky Research Foundation, Lexington, KY (US)
Wermeling, Daniel, "Intranasal Opioid Compositions" (2012). Pharmaceutical Sciences Faculty Patents. 30.